For information on previous events not listed, please contact MILI at email@example.com.
Graduate Global Enrichment in China
This program offers students an opportunity to explore the dynamics of the Chinese economy through an experiential medical technology valuation exercise. This course is modeled after Carlson School's on-campus Medical Industry Leadership Institute valuation lab which engages an interdisciplinary collaboration of students, faculty, and industry leaders working together. Working under the supervision of experience faculty members and mentors, students assess the value of proprietary inventions in the context of the Chinese market, producing a comprehensive valuation report covering all aspects of the innovation. The analysis assesses intellectual property issues, regulatory challenges, market size and growth trends, effectiveness and need for the technology and financial issues and strategic positioning.
University of Minnesota students will have an opportunity to work in cross-cultural teams with students and engineers from our partner school the University of Shanghai for Science and Technology.
Medtronic's Global Health Initiative: Innovation to Reach Underserved Patients around the World
Daniel B. Grossman, M.D., Senior Director, Global Health Innovation, Medtronic Inc.
Geoffrey S. Martha, Senior Vice President, Strategy and Business Development, Medtronic, Inc.
Herbert Hanson Hall, Room 1-102
Actuarial Seminar Series
From Health Reform to Care Reform: Top Ten Trends to Navigating the Transition
Design of Medical Devices Conference
The Commons Hotel & McNamara Alumni Center
3M Auditorium, Carlson School of Management
Minnesota Health Services Research Conference
Continuing Education and Conference Center, University of Minnesota
LifeScience Alley Conference: Healthcare Transformation - Surviving the Shift
Minneapolis Convention Center
Actuarial Seminar Series: Understanding Risk Under Health Reform: How Do Insurance Exchanges and Payment Reform Require New Approaches for Measuring and Managing Risk?
David Knutson, Senior Research Fellow, Division of Health Policy & Management, University of Minnesota
Actuarial Seminar Series: What can Massachusetts Health Care Reform teach us about the ACA?
Ian Duncan, FSA, MAAA, FCIA, FIA, Vice President, Outcomes and Analytics, Walgreen Cos.
Actuarial Seminar Series: A Detailed Look at US Health Care Spending
Julie Schoenman, PhD, Director of Research and Quality, National Institute for Health Care Management (NIHCM) Research and Educational Foundation
The John Hopkins Institute for Policy Studies continued their Social Policy Seminar Series talk with a presentation from Dr. Stephen Parente entitled, "The Evolution of Health Care Reform: Are We There Yet?".
Wedneday, September 26, 2012
Putting Providers At-Risk: How strong are incentives for upcoding and treatment changes?
Marisa Domino, PhD
Professor, Health Econmonics, Department of Healthy Policy and Management, University of North Carolina at Chapel Hill
July 18, 2012
Insiders View Seminar: The Future of Medical Production
Justin Paur, Director of Production Services and MILI Fellow, NACS, Inc.
John Stenson, FSA, MAAA
Senior Vice President and Chief Actuary, Kaiser Permanente
May 6, 2011
Benefits and Burdens of FDA Regulations on Global Medical Technology Markets
Co-sponsored by the Center for International Business Education and Research (CIBER)
This event will provide an insightful and candid set of conversations about the challenges facing the medical technology market and the evolving role of governments across the globe. This seminar is free and open to the public. Registration is required.
Podcast from "Benefits and Burdens of FDA Regulations on Global medical Technology Markets," held on May 6, 2011 is now available.
April 27, 2011
On the Determinants of Organizational Forgetting
November 22, 2010
MILI Actuarial Seminar: "Interesting Times for an Actuary: Healthcare Trends and Healthcare Reform"
M. Kent Clemens, FSA
Senior Actuary, Centers for Medicare and Medicaid Services (CMS), Office of the Actuary
Medicaid, Medicare, and total U.S. healthcare spending have received a lot of attention throughout the drive to healthcare reform. The recently-passed legislation will bring about change, but where do things stand before the reform begins? What are the expected impacts of the recently-passed healthcare reform legislation on Medicaid, Medicare, and total healthcare spending? What role have actuaries played along the way? (Actuaries are not just calculators!) View full event information (PDF).
November 8, 2010
"Nurses and Unionization"
Joanne Spetz, PhD, Professor of Community Health Systems, School of Nursing & Center for the Health Professions, University of California, San Francisco
Co-sponsored by the Department of Health Policy & Management, School of Public Health, U of MN
February 18, 2010
"Individual Health Insurance Reform without Side Effects"
Presented by Mark Pauly, PhD, Professor in the Department of Healthcare Management, Professor of Healthcare Management, Insurance and Risk Management, and Business and Public Policy at the Wharton School and Professor of Economics in the School of Arts and Sciences at the University of Pennsylvania
If you were unable to attend this seminar, you can view it here.
Co-sponsored seminar with the Department of Health Policy and Management, SPH